Allopurinol-induced pure red cell aplasia

American Journal of Hematology

Volumn 73, Issue 1, 2003, Pages 69-

  Shankar, Prashant ^a   Aish, Leo ^a   Hassoun, Hani ^b  

^a ST ELIZABETH'S MEDICAL CENTER   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; CD19 ANTIGEN; CD20 ANTIGEN; CD22 ANTIGEN;

AGED; BONE MARROW BIOPSY; CASE REPORT; CLINICAL EXAMINATION; FLOW CYTOMETRY; HUMAN; LETTER; LYMPHOPROLIFERATIVE DISEASE; MALE; PRIORITY JOURNAL; PURE RED CELL ANEMIA;

AGED; ALLOPURINOL; HUMANS; MALE; RED-CELL APLASIA, PURE;

EID: 0242432450     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajh.10315     Document Type: Letter

References (4)

1. Fisch P, Handgretinger R, Schafer HE. Pure red cell aplasia. Br J Haematol 2000;111(4):1010-1022.
2. Thompson DF, Gales MA. Drug-induced pure red cell aplasia. Pharmacotherapy 1996;16(6):1002-1008.
3. Lin Y-W, Okazaki S, Hamahata K. et al. Acute pure red cell aplasia with allopurinol therapy. Am J Hematol 1999;61:209-211.
4. Vohra RM, Sturm RE, Patel AR, et al. Pure red cell aplasia (PRCA) in association with allopurinol. Blood 1983;62(Suppl 1):51a.